Arch Biopartners

(OTC) ACHFF

Current Price$0.31

Market Cap$21.88M

Since IPO (2011)-55%

5 Year-68%

1 Year-74%

1 Month-5%

Arch Biopartners Financials at a Glance

Market Cap

$21.88M

Revenue (TTM)

$158.08K

Net Income (TTM)

$2.69M

EPS (TTM)

$-0.03

P/E Ratio

-11.03

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.31

Volume

21,500

Open

$0.31

Price

$0.31

Volume

21,500

Open

$0.31

Previous Close

$0.32

Daily Range

$0.30 - $0.31

52-Week Range

$0.30 - $1.42

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.31

Volume

21,500

Open

$0.31

Previous Close

$0.32

Daily Range

$0.30 - $0.31

52-Week Range

$0.30 - $1.42

ACHFF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arch Biopartners

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Richard Gabriel Muruve, MBA

Website

www.archbiopartners.com

Headquarters

Toronto, ON M4T 2M5, CA

ACHFF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

69%

Return on Assets

-108%

Earnings Yield

-9.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$21.88M

Shares Outstanding

67.93M

Volume

21.50K

Avg. Volume

32.65K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.50M

EBITDA

$1.29M

Operating Cash Flow

$1.59M

Capital Expenditure

$5.01

Free Cash Flow

$1.59M

Cash & ST Invst.

$2.10K

Total Debt

$2.84M

Arch Biopartners Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$21.88M

N/A

Market Cap/Employee

$3.65M

N/A

Employees

N/A

Net Income

$1.56M

-274.5%

EBITDA

$1.48M

-1496.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$2.63M

+5.2%

Accounts Receivable

$6.78K

-98.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.63M

-6.9%

Return on Assets

-107.70%

N/A

Return on Invested Capital

69.28%

N/A

Free Cash Flow

$849.25K

+6.0%

Operating Cash Flow

$849.24K

+6.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OTLCOncotelic Therapeutics, Inc.

OTLCOncotelic Therapeutics, Inc.$0.04-0.51%

ZIVOZIVO Bioscience, Inc.

ZIVOZIVO Bioscience, Inc.$3.55-6.58%

CVALFCovalon Technologies Ltd.

CVALFCovalon Technologies Ltd.$1.38-1.03%

RLFTFMindMaze Therapeutics Holding S.A.

RLFTFMindMaze Therapeutics Holding S.A.$0.44+7.43%

SPBBFSpeakeasy Cannabis Club Ltd.

SPBBFSpeakeasy Cannabis Club Ltd.$0.00+0.00%

PSYBFPsyBio Therapeutics Corp.

PSYBFPsyBio Therapeutics Corp.$0.00+0.00%

VICPVicapsys Life Sciences, Inc.

VICPVicapsys Life Sciences, Inc.$1.46+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.71+2.34%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.12+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.74+0.01%

XNDUXanadu Quantum Technologies

XNDUXanadu Quantum Technologies$14.68-0.59%

ADTADT

ADTADT$7.15-0.05%

FFord Motor Company

FFord Motor Company$11.49-0.03%

GMEGameStop

GMEGameStop$24.28-0.08%

Questions About ACHFF

What is the current price of Arch Biopartners?

Arch Biopartners is trading at $0.31 per share.

What is the 52-week range for Arch Biopartners?

Over the past 52 weeks, Arch Biopartners has traded between $0.30 and $1.42.

How much debt does Arch Biopartners have?

As of the most recent reporting period, Arch Biopartners reported total debt of $1.92M.

How much cash does Arch Biopartners have on hand?

Arch Biopartners reported $3,037.024 in cash and cash equivalents in its most recent financial results.

What is Arch Biopartners’s dividend yield?

Arch Biopartners does not currently have a dividend yield.

Arch Biopartners

Arch Biopartners Financials at a Glance

ACHFF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Arch Biopartners

ACHFF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Arch Biopartners Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACHFF

What is the current price of Arch Biopartners?

What is the 52-week range for Arch Biopartners?

How much debt does Arch Biopartners have?

How much cash does Arch Biopartners have on hand?

What is Arch Biopartners’s dividend yield?

Premium Investing Services